The Auxiliary Value of Carbon Monoxide Breath Monitors in Scientific Smoking Cessation and Tobacco Control Interventions

The Auxiliary Value of Carbon Monoxide Breath Monitors in Scientific Smoking Cessation and Tobacco Control Interventions

——A Popular Science Series on Digital Tobacco Control Tools

Tobacco smoke exposure is the leading preventable risk factor for chronic diseases and mortality in China. According to the China Report on the Health Hazards of Smoking, China is home to more than 300 million smokers, and over 1 million people die from tobacco-related diseases each year. In the process of advancing the tobacco control goals of "Healthy China 2030", the model of relying solely on verbal education and willpower-based smoking cessation can no longer meet the demand for refined interventions. Objective, quantitative and accessible monitoring tools are becoming an important pillar of the scientific tobacco control system.

Exhaled carbon monoxide (eCO) testing is a smoking exposure assessment method explicitly recommended by the Chinese Clinical Guidelines for Smoking Cessation. By non-invasively detecting the concentration of CO in exhaled breath, carbon monoxide breath monitors can quickly quantify the level of human tobacco smoke exposure, and play an irreplaceable auxiliary role in individual smoking cessation interventions and population-based tobacco control management.

I. Scientific Basis of Exhaled Carbon Monoxide Monitoring

Carbon monoxide produced by tobacco combustion enters the bloodstream through the alveoli and binds to hemoglobin to form carboxyhemoglobin (COHb), whose binding affinity is 200 to 300 times that of oxygen. Since exhaled CO concentration has a stable positive correlation with blood COHb level, exhaled breath testing can be used to indirectly reflect the degree of recent human tobacco smoke exposure.

Compared with self-reported smoking volume, salivary nicotine testing and other methods, exhaled CO monitoring has significant advantages:

Non-invasive and rapid: A single test only requires 10 seconds of exhaled breath sampling, no blood collection or laboratory processing is needed;

Objective and quantitative: It outputs accurate values in ppm, avoiding recall bias and underestimation in self-reports;

Cost-effective: The device is portable with a low operation threshold, suitable for deployment in primary care and large-scale scenarios;

Immediate feedback: Test results are available instantly, enabling simultaneous health education and behavioral intervention.

Clinical general grading reference: 0–6 ppm is the level for non-smokers, 7–10 ppm indicates mild smoke exposure, and >10 ppm suggests significant smoking exposure.

II. Core Auxiliary Value in Scientific Smoking Cessation Interventions

1. Baseline Assessment: Accurately Identifying Smoking Exposure Levels

Baseline testing with a carbon monoxide breath monitor at the first visit can objectively judge the actual exposure level and tobacco dependence degree of smokers, and assist clinicians in formulating personalized smoking cessation plans, avoiding deviations caused by assessment based solely on the number of cigarettes smoked. Data from multi-center smoking cessation clinics across China show that patients who complete baseline eCO testing have 1.87 times stronger willingness to quit smoking than those who do not, and the suitability of intervention plans is significantly improved.

2. Motivation Enhancement: Turning Invisible Hazards into Visible Data

Most smokers' understanding of tobacco hazards remains at an abstract level. Real-time displayed CO concentration values can visualize "invisible lung damage" and produce a strong biofeedback effect. When smokers see the numerical value decrease as their cigarette consumption drops, they receive immediate positive feedback, which significantly boosts their confidence in quitting and treatment adherence — an effect that is difficult to achieve through verbal persuasion alone.

3. Follow-up Management: Objectively Verifying Abstinence Effects and Reducing Relapse Risk

During smoking cessation follow-up, self-reported "quitting smoking" has high rates of underreporting and unreported relapse. Carbon monoxide breath monitors can serve as an objective verification tool to quickly identify hidden relapse and help clinicians intervene in a timely manner. Research data shows that patients who receive eCO follow-up monitoring have a 22% higher 3-month sustained smoking cessation rate than the traditional follow-up group.

4. Combined Intervention: Building an "Assessment-Intervention-Monitoring" Closed Loop

Carbon monoxide breath monitors can be deeply integrated with pharmacotherapy, behavioral intervention, online health management and other models: they can evaluate biological response when used with smoking cessation medications; enhance intervention effects when paired with motivational interviewing; and enable at-home self-testing, data upload and remote guidance when combined with online smoking cessation platforms, forming a complete closed loop of scientific smoking cessation.

III. Multi-scenario Applications in Population-based Tobacco Control

1. Standardized Configuration for Smoking Cessation Clinics at All Levels of Medical Institutions

From respiratory departments in tertiary hospitals to community health service centers, carbon monoxide breath monitors are basic equipment for smoking cessation clinics. As China's smoking cessation clinic network extends to primary care settings, portable monitoring devices can help district/county and township-level health institutions quickly carry out standardized smoking cessation services, narrowing the gap in tobacco control service capacity between regions.

2. Community and Public Health Tobacco Control Education

In community health screenings and smoke-free community initiatives, exhaled CO testing can be used as an interactive science popularization tool to attract residents to actively participate in tobacco hazard testing, and improve the acceptance and retention of tobacco control education. This model is applicable to population-based tobacco control activities of CDCs and community health service centers across all provinces and cities in China, with strong regional replicability.

3. Tobacco Control in Enterprises, Institutions and Public Places

In smoke-free workplace construction and workplace tobacco control management, exhaled CO testing can be used for tobacco control supervision in key positions and employee health screenings, helping enterprises establish objective and enforceable tobacco control management systems. It is applicable to factories, office buildings, industrial parks and various other places.

4. Online Smoking Cessation and At-home Self-management

Combined with consumer-grade portable carbon monoxide breath monitors, smokers can complete daily monitoring at home, and synchronize data to smoking cessation clinicians or health managers through online platforms, realizing professional smoking cessation guidance "without leaving home". This model can effectively cover remote areas and people in sinking markets, expand the geographic radius of tobacco control services, and promote the equalization of tobacco control services nationwide.

IV. Application Prospects

As China's tobacco control work develops toward digitalization and refinement, the application boundaries of carbon monoxide breath monitors continue to expand:

Combined with AI algorithms and big data analysis, more accurate smoking cessation risk prediction and personalized intervention recommendations can be realized;

When included in primary public health service packages, they can become standard equipment for county-level tobacco control capacity building;

Extended to special population scenarios such as youth tobacco control and passive smoking monitoring for pregnant women, they can play a role in early screening and early intervention.

It should be clarified that carbon monoxide breath monitors are auxiliary tools and assessment means for tobacco control interventions, and do not replace professional smoking cessation diagnosis and treatment and pharmacotherapy. Under the tobacco control policy of "prevention first, combination of prevention and treatment", supporting scientific intervention with objective monitoring will continue to help steadily achieve tobacco control goals.